rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1993-9-23
|
pubmed:abstractText |
Patients with hypertensive crises often experience reduced renal function that may worsen as the elevated blood pressure is treated. Fenoldopam, a novel, peripherally acting dopamine-1 agonist, lowers blood pressure through arteriolar vasodilation, with particularly prominent effects on the renal vascular bed. This study was conducted to examine the effects of fenoldopam on blood pressure and renal function compared to those of sodium nitroprusside in severely hypertensive patients with impaired renal function.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0002-9343
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
161-8
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8102835-2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine,
pubmed-meshheading:8102835-Adult,
pubmed-meshheading:8102835-Creatinine,
pubmed-meshheading:8102835-Female,
pubmed-meshheading:8102835-Fenoldopam,
pubmed-meshheading:8102835-Hemodynamics,
pubmed-meshheading:8102835-Humans,
pubmed-meshheading:8102835-Hypertension,
pubmed-meshheading:8102835-Kidney,
pubmed-meshheading:8102835-Kidney Function Tests,
pubmed-meshheading:8102835-Male,
pubmed-meshheading:8102835-Middle Aged,
pubmed-meshheading:8102835-Nitroprusside,
pubmed-meshheading:8102835-Renal Insufficiency,
pubmed-meshheading:8102835-Severity of Illness Index,
pubmed-meshheading:8102835-Vasodilator Agents
|
pubmed:year |
1993
|
pubmed:articleTitle |
Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
|
pubmed:affiliation |
SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|